Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening

Molecular Pharmaceutics

Volumn 11, Issue 7, 2014, Pages 2040-2050

  Fong, Eliza L S ^b   Martinez, Mariane ^a   Yang, Jun ^c   Mikos, Antonios G ^b   Navone, Nora M ^c   Harrington, Daniel A ^a   Farach Carson, Mary C ^a,b  

^a RICE UNIVERSITY   (United States)

^b Rice University   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

drug; hydrogel; Patient derived xenograft; prostate cancer; tumor

Indexed keywords

ANDROGEN RECEPTOR; DOCETAXEL; HYALURONIC ACID; ANTINEOPLASTIC AGENT; AR PROTEIN, HUMAN; HYDROGEL; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG SCREENING; HYDROGEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TISSUE CULTURE; TUMOR XENOGRAFT; ANIMAL; CELL SURVIVAL; DRUG EFFECTS; HUMAN; MALE; METABOLISM; PHARMACOLOGY; PRECLINICAL STUDY; PROCEDURES; PROSTATE; PROSTATIC NEOPLASMS; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG EVALUATION, PRECLINICAL; HUMANS; HYALURONIC ACID; HYDROGEL; MALE; MICE; MICE, SCID; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TAXOIDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84904011702     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500085p     Document Type: Article

References (32)

1. Jacobs, S. C. Spread of prostatic cancer to bone Urology 1983, 21 (4) 337-44
2. Logothetis, C. J.; Navone, N. M.; Lin, S. H. Understanding the biology of bone metastases: key to the effective treatment of prostate cancer Clin. Cancer Res. 2008, 14 (6) 1599-602
3. Begley, C. G.; Ellis, L. M. Drug development: Raise standards for preclinical cancer research Nature 2012, 483 (7391) 531-3
4. Thalmann, G. N.; Sikes, R. A.; Wu, T. T.; Degeorges, A.; Chang, S. M.; Ozen, M.; Pathak, S.; Chung, L. W. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis Prostate 2000, 44 (2) 91-103
5. Tentler, J. J.; Tan, A. C.; Weekes, C. D.; Jimeno, A.; Leong, S.; Pitts, T. M.; Arcaroli, J. J.; Messersmith, W. A.; Eckhardt, S. G. Patient-derived tumour xenografts as models for oncology drug development Nat. Rev. Clin. Oncol. 2012, 9 (6) 338-50
6. Gray, D. R.; Huss, W. J.; Yau, J. M.; Durham, L. E.; Werdin, E. S.; Funkhouser, W. K., Jr.; Smith, G. J. Short-term human prostate primary xenografts: an in vivo model of human prostate cancer vasculature and angiogenesis Cancer Res. 2004, 64 (5) 1712-21
7. Toivanen, R.; Frydenberg, M.; Murphy, D.; Pedersen, J.; Ryan, A.; Pook, D.; Berman, D. M.; Australian Prostate Cancer BioResource; Taylor, R. A.; Risbridger, G. P. A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors Sci. Transl. Med. 2013, 5 (187) 187ra71
8. Yoshida, T.; Kinoshita, H.; Segawa, T.; Nakamura, E.; Inoue, T.; Shimizu, Y.; Kamoto, T.; Ogawa, O. Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient Cancer Res. 2005, 65 (21) 9611-6
9. Siolas, D.; Hannon, G. J. Patient-derived tumor xenografts: transforming clinical samples into mouse models Cancer Res. 2013, 73 (17) 5315-9
10. Gurski, L. A.; Jha, A. K.; Zhang, C.; Jia, X.; Farach-Carson, M. C. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells Biomaterials 2009, 30 (30) 6076-85
11. Gurski, L. A.; Xu, X.; Labrada, L. N.; Nguyen, N. T.; Xiao, L.; van Golen, K. L.; Jia, X.; Farach-Carson, M. C. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels PLoS One 2012, 7 (11) e50075
12. Xu, X.; Gurski, L. A.; Zhang, C.; Harrington, D. A.; Farach-Carson, M. C.; Jia, X. Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids Biomaterials 2012, 33 (35) 9049-60
13. Burdett, E.; Kasper, F. K.; Mikos, A. G.; Ludwig, J. A. Engineering tumors: a tissue engineering perspective in cancer biology Tissue Eng., Part B 2010, 16 (3) 351-9
14. Toole, B. P. Hyaluronan: from extracellular glue to pericellular cue Nat. Rev. Cancer 2004, 4 (7) 528-39
15. Zheng Shu, X.; Liu, Y.; Palumbo, F. S.; Luo, Y.; Prestwich, G. D. In situ crosslinkable hyaluronan hydrogels for tissue engineering Biomaterials 2004, 25 (7-8) 1339-48
16. Vanderhooft, J. L.; Alcoutlabi, M.; Magda, J. J.; Prestwich, G. D. Rheological properties of cross-linked hyaluronan-gelatin hydrogels for tissue engineering Macromol. Biosci. 2009, 9 (1) 20-8
17. Ghosh, K.; Shu, X. Z.; Mou, R.; Lombardi, J.; Prestwich, G. D.; Rafailovich, M. H.; Clark, R. A. Rheological characterization of in situ cross-linkable hyaluronan hydrogels Biomacromolecules 2005, 6 (5) 2857-65
18. Li, Z. G.; Mathew, P.; Yang, J.; Starbuck, M. W.; Zurita, A. J.; Liu, J.; Sikes, C.; Multani, A. S.; Efstathiou, E.; Lopez, A.; Wang, J.; Fanning, T. V.; Prieto, V. G.; Kundra, V.; Vazquez, E. S.; Troncoso, P.; Raymond, A. K.; Logothetis, C. J.; Lin, S. H.; Maity, S.; Navone, N. M. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms J. Clin. Invest. 2008, 118 (8) 2697-710
19. Allen, R. G.; Eisenberg, S. R.; Gray, M. L. Quantitative measurement of the biological response of cartilage to mechanical deformation Methods Mol. Med. 1999, 18, 521-42
20. Shen, X.; Kramer, R. H. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor Am. J. Pathol. 2004, 165 (4) 1315-29
21. Kondo, J.; Endo, H.; Okuyama, H.; Ishikawa, O.; Iishi, H.; Tsujii, M.; Ohue, M.; Inoue, M. Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (15) 6235-40
22. Karlou, M.; Lu, J. F.; Wu, G.; Maity, S.; Tzelepi, V.; Navone, N. M.; Hoang, A.; Logothetis, C. J.; Efstathiou, E. Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b Prostate 2012, 72 (15) 1638-47
23. Massie, C. E.; Lynch, A.; Ramos-Montoya, A.; Boren, J.; Stark, R.; Fazli, L.; Warren, A.; Scott, H.; Madhu, B.; Sharma, N.; Bon, H.; Zecchini, V.; Smith, D. M.; Denicola, G. M.; Mathews, N.; Osborne, M.; Hadfield, J.; Macarthur, S.; Adryan, B.; Lyons, S. K.; Brindle, K. M.; Griffiths, J.; Gleave, M. E.; Rennie, P. S.; Neal, D. E.; Mills, I. G. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis EMBO J. 2011, 30 (13) 2719-33
24. Heinlein, C. A.; Chang, C. Androgen receptor in prostate cancer Endocrine Rev. 2004, 25 (2) 276-308
25. Gelmann, E. P. Molecular biology of the androgen receptor J. Clin. Oncol. 2002, 20 (13) 3001-15
26. Rathkopf, D.; Scher, H. I. Androgen receptor antagonists in castration-resistant prostate cancer Cancer J. 2013, 19 (1) 43-9
27. Gillet, J. P.; Calcagno, A. M.; Varma, S.; Marino, M.; Green, L. J.; Vora, M. I.; Patel, C.; Orina, J. N.; Eliseeva, T. A.; Singal, V.; Padmanabhan, R.; Davidson, B.; Ganapathi, R.; Sood, A. K.; Rueda, B. R.; Ambudkar, S. V.; Gottesman, M. M. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (46) 18708-13
28. Zhu, M. L.; Horbinski, C. M.; Garzotto, M.; Qian, D. Z.; Beer, T. M.; Kyprianou, N. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer Cancer Res. 2010, 70 (20) 7992-8002
29. Daniel, V. C.; Marchionni, L.; Hierman, J. S.; Rhodes, J. T.; Devereux, W. L.; Rudin, C. M.; Yung, R.; Parmigiani, G.; Dorsch, M.; Peacock, C. D.; Watkins, D. N. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro Cancer Res. 2009, 69 (8) 3364-73
30. Landis, M. D.; Lehmann, B. D.; Pietenpol, J. A.; Chang, J. C. Patient-derived breast tumor xenografts facilitating personalized cancer therapy Breast Cancer Res. 2013, 15 (1) 201
31. Burdall, S. E.; Hanby, A. M.; Lansdown, M. R.; Speirs, V. Breast cancer cell lines: friend or foe? Breast Cancer Res. 2003, 5 (2) 89-95
32. Weiswald, L. B.; Richon, S.; Validire, P.; Briffod, M.; Lai-Kuen, R.; Cordelieres, F. P.; Bertrand, F.; Dargere, D.; Massonnet, G.; Marangoni, E.; Gayet, B.; Pocard, M.; Bieche, I.; Poupon, M. F.; Bellet, D.; Dangles-Marie, V. Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness Br. J. Cancer 2009, 101 (3) 473-82